ストックスクリーナーアプリを入手
0.4013
0.63%
0.0013
前日終値:
$0.40
開ける：
$0.3931
24時間の取引高:
35,380
Relative Volume:
0.07
時価総額：
$15.87M
収益：
-
当期純損益:
$-117.67M
株価収益率:
-0.1299
EPS:
-3.09
ネットキャッシュフロー:
$-101.06M
1週間 パフォーマンス:
+2.05%
1か月 パフォーマンス:
-2.50%
6か月 パフォーマンス:
-2.00%
1年 パフォーマンス:
-87.77%
1日の値動き範囲:
$0.3917
$0.4025
1週間の範囲:
$0.3801
$0.4124
52週間の値動き範囲:
$0.2195
$3.34
Athira Pharma Inc Stock (ATHA) Company Profile
名前
Athira Pharma Inc
セクター
電話
(425) 620-8501
住所
18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL
ATHA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ATHA
Athira Pharma Inc
|
0.4025 | 15.97M | 0 | -117.67M | -101.06M | -3.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.14 | 99.76B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
579.00 | 62.21B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.81 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
700.80 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.47 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Athira Pharma Inc Stock (ATHA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-09-19 | ダウングレード | Mizuho | Outperform → Neutral |
| 2024-09-04 | ダウングレード | BTIG Research | Buy → Neutral |
| 2024-09-04 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-09-04 | ダウングレード | Rodman & Renshaw | Buy → Neutral |
| 2024-08-19 | 開始されました | Rodman & Renshaw | Buy |
| 2022-10-17 | アップグレード | JMP Securities | Mkt Perform → Mkt Outperform |
| 2022-07-07 | 開始されました | Mizuho | Buy |
| 2022-06-23 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-06-23 | ダウングレード | Jefferies | Buy → Hold |
| 2022-06-23 | ダウングレード | Stifel | Buy → Hold |
| 2022-05-10 | 開始されました | BTIG Research | Buy |
| 2022-04-21 | 開始されました | Berenberg | Buy |
| 2021-12-15 | 開始されました | Goldman | Neutral |
| 2020-10-13 | 開始されました | Goldman | Buy |
| 2020-10-13 | 開始されました | JMP Securities | Mkt Outperform |
| 2020-10-13 | 開始されました | Jefferies | Buy |
| 2020-10-13 | 開始されました | Stifel | Buy |
すべてを表示
Athira Pharma Inc (ATHA) 最新ニュース
Advanced analytics toolkit walkthrough for Athira Pharma Inc.Weekly Earnings Recap & AI Powered Buy/Sell Recommendations - Newser
Using economic indicators to assess Athira Pharma Inc. potential2025 Trade Ideas & Real-Time Chart Breakout Alerts - Newser
Smart tools for monitoring Athira Pharma Inc.’s price actionDay Trade & AI Enhanced Trading Signals - Newser
Using data filters to optimize entry into Athira Pharma Inc.Weekly Risk Report & Free Real-Time Volume Trigger Notifications - Newser
What’s next for Athira Pharma Inc. stock priceJuly 2025 Market Mood & Precise Entry and Exit Recommendations - Newser
Visualizing Athira Pharma Inc. stock with heatmapsWeekly Stock Summary & Daily Stock Trend Reports - Newser
Price action breakdown for Athira Pharma Inc.Weekly Stock Report & Risk Controlled Swing Alerts - Newser
Published on: 2025-08-28 00:30:41 - Newser
Real time pattern detection on Athira Pharma Inc. stock2025 Market Sentiment & Stepwise Entry/Exit Trade Alerts - Newser
Is Athira Pharma Inc. meeting your algorithmic filter criteriaJuly 2025 Sector Moves & Verified Stock Trade Ideas - Newser
Leading vs lagging indicators on Athira Pharma Inc. performanceJuly 2025 Breakouts & Verified Chart Pattern Signals - Newser
Published on: 2025-08-27 13:16:08 - Newser
What moving averages say about Athira Pharma Inc.Gold Moves & AI Enhanced Trading Signals - Newser
What does recent volatility data suggest for Athira Pharma Inc.Market Activity Report & Weekly Return Optimization Plans - Newser
Will Athira Pharma Inc. rebound enough to break even2025 Trading Recap & Daily Stock Trend Reports - Newser
Price momentum metrics for Athira Pharma Inc. explained2025 Winners & Losers & Long-Term Growth Plans - Newser
Sentiment analysis tools applied to Athira Pharma Inc.Quarterly Portfolio Summary & Community Consensus Trade Signals - Newser
Applying Elliott Wave Theory to Athira Pharma Inc.Market Growth Review & Safe Swing Trade Setups - Newser
Is Athira Pharma Inc. a candidate for recovery playMarket Growth Report & Expert Approved Momentum Trade Ideas - Newser
How to build a dashboard for Athira Pharma Inc. stock2025 Volume Leaders & Weekly Momentum Picks - Newser
Is Athira Pharma Inc. building a consolidation base2025 Historical Comparison & Risk Adjusted Buy and Sell Alerts - Newser
Athira Pharma Inc. stock prediction for this weekJuly 2025 EndofMonth & Safe Capital Growth Tips - Newser
Athira Pharma Inc. Sees Spike in Bullish Option FlowJuly 2025 Sector Moves & Verified Momentum Stock Alerts - beatles.ru
Is Athira Pharma Inc. forming a breakout patternMarket Performance Report & Short-Term Trading Opportunity Alerts - theviewers.co.kr
Will Athira Pharma Inc. face regulatory challengesFed Meeting & Daily Oversold Stock Bounce Ideas - theviewers.co.kr
Has Athira Pharma Inc. found a price floorAnalyst Downgrade & Free Long-Term Investment Growth Plans - Newser
Pullback Watch: Will Athira Pharma Inc. benefit from AI trends2025 Geopolitical Influence & Consistent Income Trade Ideas - theviewers.co.kr
Bull Run: Will Athira Pharma Inc. benefit from AI trendsTrade Risk Report & Weekly Hot Stock Watchlists - theviewers.co.kr
Screener Results Flag Athira Pharma Inc. as OversoldEarnings Risk Summary & Reliable Intraday Trade Plans - beatles.ru
MACD Cross Could Confirm Trend in Athira Pharma Inc.July 2025 Rallies & Verified Swing Trading Watchlists - beatles.ru
Athira Pharma Inc. Matches Institutional Buying FilterJuly 2025 Decliners & Reliable Breakout Forecasts - classian.co.kr
Watch for Bullish Crossover in Athira Pharma Inc.July 2025 Movers & Weekly Sector Rotation Insights - newsyoung.net
Athira Pharma Inc. Testing Reversal Zone on Weekly Chart2025 Bull vs Bear & Intraday High Probability Alerts - 더경남뉴스
Athira Pharma Inc (ATHA) 財務データ
収益
当期純利益
現金流量
EPS
Athira Pharma Inc (ATHA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER |
Jul 01 '25 |
Sale |
0.29 |
8,526 |
2,502 |
168,901 |
| Litton Mark James | President and CEO |
Jun 30 '25 |
Option Exercise |
0.00 |
108,334 |
0 |
350,925 |
| Litton Mark James | President and CEO |
Jul 01 '25 |
Sale |
0.29 |
25,123 |
7,374 |
325,802 |
| San Martin Javier | CHIEF MEDICAL OFFICER |
Jun 30 '25 |
Option Exercise |
0.00 |
46,666 |
0 |
82,507 |
| San Martin Javier | CHIEF MEDICAL OFFICER |
Jul 01 '25 |
Sale |
0.29 |
10,842 |
3,182 |
71,665 |
| Worthington Mark | General Counsel and CCO |
Jun 30 '25 |
Option Exercise |
0.00 |
36,666 |
0 |
120,401 |
| Worthington Mark | General Counsel and CCO |
Jul 01 '25 |
Sale |
0.29 |
8,526 |
2,502 |
111,875 |
| Renninger Robert | SVP, Finance and Accounting |
Jun 30 '25 |
Option Exercise |
0.00 |
12,359 |
0 |
112,083 |
| Renninger Robert | SVP, Finance and Accounting |
Jul 01 '25 |
Sale |
0.29 |
2,897 |
850 |
109,186 |
1.41%
0.71%
大文字化:
|
ボリューム (24 時間):